Clinical Trial Detail

NCT ID NCT03879811
Title Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

colorectal cancer

Therapies

Nivolumab

Temozolomide

Age Groups: adult senior

No variant requirements are available.